These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26136324)

  • 1. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
    Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
    No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomas.
    Aoki T; Nishikawa R; Sugiyama K; Nonoguchi N; Kawabata N; Mishima K; Adachi J; Kurisu K; Yamasaki F; Tominaga T; Kumabe T; Ueki K; Higuchi F; Yamamoto T; Ishikawa E; Takeshima H; Yamashita S; Arita K; Hirano H; Yamada S; Matsutani M;
    Neurol Med Chir (Tokyo); 2014; 54(4):290-301. PubMed ID: 24739422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
    Ashby LS; Smith KA; Stea B
    World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
    Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
    Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
    Nagpal S
    Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Gliadel wafers in the treatment of high-grade gliomas.
    Bregy A; Shah AH; Diaz MV; Pierce HE; Ames PL; Diaz D; Komotar RJ
    Expert Rev Anticancer Ther; 2013 Dec; 13(12):1453-61. PubMed ID: 24236823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carmustine wafer implantation when surgical cavity is communicating with cerebral ventricles: technical considerations on a clinical series.
    Della Puppa A; Rossetto M; Ciccarino P; Denaro L; Rotilio A; d'Avella D; Scienza R
    World Neurosurg; 2011; 76(1-2):156-9; discussion 67-8. PubMed ID: 21839967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral edema associated with Gliadel wafers: two case studies.
    Weber EL; Goebel EA
    Neuro Oncol; 2005 Jan; 7(1):84-9. PubMed ID: 15701285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Space-occupying cyst development in the resection cavity of malignant gliomas following Gliadel® implantation--incidence, therapeutic strategies, and outcome.
    Dörner L; Ulmer S; Rohr A; Mehdorn HM; Nabavi A
    J Clin Neurosci; 2011 Mar; 18(3):347-51. PubMed ID: 21237660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
    Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
    Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.
    Xing WK; Shao C; Qi ZY; Yang C; Wang Z
    Drug Des Devel Ther; 2015; 9():3341-8. PubMed ID: 26170620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.
    Chowdhary SA; Ryken T; Newton HB
    J Neurooncol; 2015 Apr; 122(2):367-82. PubMed ID: 25630625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk management in the treatment of malignant gliomas with BCNU wafer implants.
    Giese A; Bock HC; Kantelhardt SR; Rohde V
    Cent Eur Neurosurg; 2010 Nov; 71(4):199-206. PubMed ID: 20063259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers.
    Murai S; Ichikawa T; Kurozumi K; Shimazu Y; Oka T; Otani Y; Shimizu T; Date I
    J Clin Neurosci; 2016 Nov; 33():148-153. PubMed ID: 27452129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience.
    Bock HC; Puchner MJ; Lohmann F; Schütze M; Koll S; Ketter R; Buchalla R; Rainov N; Kantelhardt SR; Rohde V; Giese A
    Neurosurg Rev; 2010 Oct; 33(4):441-9. PubMed ID: 20706757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: efficacy and toxicity.
    Miglierini P; Bouchekoua M; Rousseau B; Hieu PD; Malhaire JP; Pradier O
    Clin Neurol Neurosurg; 2012 Nov; 114(9):1222-5. PubMed ID: 22464950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.
    Kleinberg LR; Weingart J; Burger P; Carson K; Grossman SA; Li K; Olivi A; Wharam MD; Brem H
    Cancer Invest; 2004; 22(1):1-9. PubMed ID: 15069758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series.
    Della Puppa A; Rossetto M; Ciccarino P; Del Moro G; Rotilio A; Manara R; Paola Gardiman M; Denaro L; d'Avella D; Scienza R
    Acta Neurochir (Wien); 2010 Nov; 152(11):1923-31. PubMed ID: 20703889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility of the adjunct of local chemotherapy with biodegradable carmustine (BCNU) wafers to the standard multimodal approach to high grade gliomas at first diagnosis.
    Salvati M; D'elia A; Frati A; Brogna C; Santoro A; Delfini R
    J Neurosurg Sci; 2011 Mar; 55(1):1-6. PubMed ID: 21464805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic meningitis triggered by implanted Gliadel wafers: case report.
    Saito K; Yamasaki K; Yokogami K; Ivanova A; Takeishi G; Sato Y; Takeshima H
    J Neurosurg; 2017 Jun; 126(6):1783-1787. PubMed ID: 27285546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.